Galectin-3: a possible complementary marker to the PSA blood test
The prostate-specific antigen (PSA) test has served as a blood marker of prostate cancer (PCa), and for monitoring recurrence/metastasis in patients after therapeutic intervention. However, the applicability/reliability of the PSA test was recently questioned as it is not without challenges, in part...
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
Impact Journals LLC
2013
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3720602/ |